Smartwatches Can Help People Control Diabetes Through Exercise
By Dennis Thompson HealthDay Reporter
MONDAY, March 31, 2025 -- Wearing a smartwatch might do more than track steps (or your texts) -- it could be a powerful tool for helping people with type 2 diabetes stay active, a new study says.
Participants were more likely to start and maintain an exercise regimen if they had a smartwatch providing them feedback and encouragement, researchers reported March 27 in the journal BMJ Open.
Early results also indicate that they were achieving better control over their blood sugar levels and blood pressure, researchers report.
“The results of this study can contribute to change the lives of many people around the world,” said researcher Ceu Mateus, a professor of health economics at Lancaster University in the U.K.
“There are millions of people suffering from diabetes type 2 without access to non-pharmacological interventions with sustained results in the long term,” she added in a news release. “Our study shows that independently of the place where you live, your age, your ethnicity, your gender, or your income, there is an exercise program that suits you.”
For the study, researchers recruited 135 people newly diagnosed with type 2 diabetes, and assigned half to wear a smartwatch paired with a health app on their smartphone.
The app guided participants through a home-based physical activity program, using the watch to track their metrics.
The program gradually increased their exercise to a target of 150 minutes per week of moderate- to vigorous-intensity physical activity. Participants also were supported by an online coaching service led by exercise specialists.
“The program offered a variety of workouts, including cardio and strength training, that could be done without the need for a gym,” lead researcher Katie Hesketh, an assistant professor in exercise prescription at the University of Birmingham, said in a news release. “Its goal is to make exercise a sustainable part of daily life for people with type 2 diabetes, ultimately improving their physical and mental health.”
Those who were given a smartwatch were 10 times more likely to start an exercise program than those who weren’t, results show, and three times more likely to still participate in that program a year later.
“We found that using biometrics from wearable technologies offered great promise for encouraging people with newly diagnosed type 2 diabetes to maintain a home-delivered, personalized exercise program with all the associated health benefits,” Hesketh concluded.
Based on these results, researchers plan to seek funding for a larger clinical trial that could see whether the smartwatch-based fitness program can actually help people with type 2 diabetes achieve control over their condition.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-01 00:00
Read more

- New Surgical Technique Preserves Erectile Function In Prostate Cancer Patients
- Sensorized T-Shirt Enables Early Discharge After Oncological Urology Surgery
- Lower Rates of Symptom Rebound Seen After H. Pylori Eradication in GERD
- GLP-1 Drug Use For Weight Loss Has Soared, Costing Billions
- People With Disabilities Often Feel Disrespected by Health Care Workers
- Free COVID-19 Test Program Stops Taking Orders
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions